GlassScriptPhysician profile
Matthew P Smith
NPI 1811515521
$3,059.47
in general payments reported to CMS, 2019-2025
17 companies · $932 in 2025
The $932 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $314 · 2023: $697 · 2024: $657 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,285.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,393.11 | 2022-2025 | Qelbree, Qelbree |
| Neurocrine Biosciences, INC. | $534.94 | 2022-2025 | Ingrezza |
| Validus Pharmaceuticals LLC | $262.25 | 2021-2023 | Equetro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $248.72 | 2021-2025 | Caplyta |
| Abbvie INC. | $153.76 | 2025 | |
| Daiichi Sankyo INC. | $74.02 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $70.37 | 2022-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $54.08 | 2021 | |
| Axsome Therapeutics, INC. | $52.49 | 2023-2025 | Auvelity |
| Seagen INC. | $41.84 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $38.89 | 2025 | Jornay Pm |
| Neuronetics, INC. | $30.44 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.44 | 2021 | |
| Adlon Therapeutics L.P. | $27.98 | 2021 | |
| Corium, LLC | $18.99 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $16.32 | 2024 | Sublocade |
| Janssen Biotech, INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.